Agilent | Trusted AnswersAgilent | Trusted Answers

Successful Workflows for Fast and Accurate Results

Visit Agilent at USCAP 2025  |  Booth 512

USCAP 2025 | Agilent
Dako Omnis

Stop by and see us in Booth 512

Find out how you can achieve efficiency and precision with our solutions, from tissue staining and companion diagnostics to digital pathology, NGS, and flow cytometry. Trust Agilent for fast, accurate results.

  • Watch live demos of our digital pathology solutions including scanning, image management and AI-driven image analysis*
  • Discuss our end-to-end pathology solutions or join our express talks on workflow and multiplexing
  • See how the Magnis NGS Prep System* and NovoCyte Opteon* spectral flow cytometer can optimize your lab

*For Research Use Only. Not for use in diagnostic procedures.

Join Agilent at USCAP 2025 for a series of thought-provoking symposia, where we delve into the latest advancements in companion diagnostics and digital pathology. The seminars promise to offer invaluable insights and foster lively discussions among industry experts and attendees.

Advancing Diagnostics: Cutting-Edge Innovations and Insights in Digital Pathology
Monday, March 24 | 12:00 - 1:00
Seminar Room 4
Lunch provided

PD-L1 Heterogeneity Across the Patient Journey
Monday, March 24 | 5:30 - 7:00
Seminar Room 3
Food and drinks provided

A Simplified Approach to Scoring Combined Positive Score (CPS) Using Agilent’s PD-L1 IHC 22C3 PharmDx Assay
Tuesday, March 25 | 12:00 - 1:00
Seminar Room 4
Lunch provided

Learn more

D0128210_1.00

Agilent at USCAP 2025

Fill in your information below to schedule a demo or learn more about what Agilent is bringing to USCAP 2025. A representative will be in touch shortly.

Your Personal Data

* This field is required

Please select your application interest(s) from choices below.

Please select your technique(s) from choices below.

Your Purchase Plan











For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy